Skip to main content
28 Sep | 2020

Avalanche of data against Alzheimer's

The digitization of the data collected in our studies allows us to accelerate our research, improve its integrity and make it available to researchers around the world.

16 Sep | 2020

The FDA accepts license application for aducanumab, the first possible disease modifying drug for Alzheimer’s

Dr José Luis Molinuevo comments the possible approval of Biogen’s new treatment, in an interview for the podcast Saving Minds.

04 Sep | 2020

Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

07 Aug | 2020

BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020

The most prominent congress dedicated to Alzheimer's research has been held completely virtual

03 Aug | 2020

Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy

23 Jul | 2020

Explore BBRC research at the AAIC 2020

Check out the oral presentations, posters and collaborations of the researchers of the Alzheimer’s Prevention Program

14 Jul | 2020

The 2019 Annual Report of the Barcelonaβeta Brain Research Center is now available

The document is a compilation with the most outstanding information on the scientific, social and economic activity of the BBRC and the Pasqual Maragall Foundation